April 2025

Source: PharmaVoice The tariff war has prompted new calls to reshore manufacturing. Several large organizations have already made the leap as BioPharma leverages technological advances such as continuous manufacturing, AI-enabled processes, robotics and automation have brought labor costs down, and regulators are offering more support. READ FULL ARTICLE Source: Reuters Read more…

Pharmaceutical advisory boards are vital opportunities to gather expert input, but their success depends greatly on planning and facilitation. Too often, companies treat key opinion leaders (KOLs) like celebrities rather than partners, stifling honest feedback and diverse perspectives. The real value emerges when facilitators create an environment where all participants Read more…